6446 — PHARMAESSENTIA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual income statement for PHARMAESSENTIA, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	557	657	2,882	5,106	9,735
Cost of Revenue
Gross Profit	184	278	2,070	4,495	8,558
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,251	3,464	4,910	7,019	7,999
Operating Profit	-1,693	-2,808	-2,028	-1,913	1,736
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,925	-2,796	-1,842	-987	2,995
Provision for Income Taxes
Net Income After Taxes	-1,926	-2,796	-1,375	-624	2,966
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,926	-2,796	-1,375	-624	2,966
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1,926	-2,796	-1,375	-624	2,966
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-7.1	-9.58	-4.36	-1.74	8
Dividends per Share